ASP Isotopes (NASDAQ:ASPI) Shares Down 5.3% - Here's Why

Key Points

• ASP Isotopes shares fell 5.3% to $3.805, with trading volume down 85% from its average. The stock remains below its 50-day and 200-day moving averages.
• The company reported a quarterly loss of $0.28 per share, missing analyst expectations of a $0.17 loss, although revenue of $5.12 million exceeded estimates.
• Analyst sentiment is mixed, resulting in a consensus “Hold” rating and a $13 price target. Insiders have sold about $1.35 million of stock over the past three months, primarily to cover tax obligations on vested equity awards.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shares traded down 5.3% during trading on Tuesday . The stock traded as low as $3.73 and last traded at $3.8050. Approximately 694,779 shares were traded during trading, a decline of 85% from the average daily volume of 4,787,871 shares. The stock had previously closed at $4.02.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Wall Street Zen upgraded shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a report on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $13.00.

ASP Isotopes Trading Down 5.3%

The stock has a 50-day moving average price of $4.59 and a two-hundred day moving average price of $5.24. The stock has a market cap of $583.34 million, a PE ratio of -2.89 and a beta of 3.61. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The business had revenue of $5.12 million during the quarter, compared to analysts' expectations of $4.47 million.

Insider Buying and Selling

In other news, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total value of $145,218.72. Following the transaction, the chief financial officer owned 1,526,252 shares of the company's stock, valued at $9,584,862.56. The trade was a 1.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Robert Ainscow sold 8,438 shares of the company's stock in a transaction on Monday, June 8th. The stock was sold at an average price of $7.00, for a total value of $59,066.00. Following the transaction, the chief operating officer directly owned 2,281,879 shares in the company, valued at approximately $15,973,153. The trade was a 0.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 195,321 shares of company stock valued at $1,354,855 over the last three months. Corporate insiders own 14.40% of the company's stock.

Institutional Trading of ASP Isotopes

Several institutional investors have recently bought and sold shares of ASPI. State of Wyoming acquired a new stake in shares of ASP Isotopes in the first quarter valued at about $29,000. Quantbot Technologies LP acquired a new position in shares of ASP Isotopes in the third quarter worth $34,000. BNP Paribas Financial Markets raised its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock valued at $41,000 after purchasing an additional 2,548 shares in the last quarter. Stephens Inc. AR purchased a new stake in shares of ASP Isotopes during the 1st quarter worth $44,000. Finally, Broadhurst Jeffrey B acquired a new position in shares of ASP Isotopes during the 1st quarter worth about $44,000. 16.80% of the stock is owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source